GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » FCF Yield %

Kyverna Therapeutics (Kyverna Therapeutics) FCF Yield % : -13.51 (As of Jun. 23, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kyverna Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kyverna Therapeutics's Trailing 12-Month Free Cash Flow is $-44.97 Mil, and Market Cap is $332.85 Mil. Therefore, Kyverna Therapeutics's FCF Yield % for today is -13.51%.

The historical rank and industry rank for Kyverna Therapeutics's FCF Yield % or its related term are showing as below:

KYTX' s FCF Yield % Range Over the Past 10 Years
Min: -13.51   Med: -3.94   Max: -2.62
Current: -13.51

During the past 3 years, the highest FCF Yield % of Kyverna Therapeutics was -2.62%. The lowest was -13.51%. And the median was -3.94%.

KYTX's FCF Yield % is ranked better than
51.87% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs KYTX: -13.51

Kyverna Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Kyverna Therapeutics FCF Yield % Historical Data

The historical data trend for Kyverna Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyverna Therapeutics FCF Yield % Chart

Kyverna Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -

Kyverna Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial - - - - -9.74

Competitive Comparison of Kyverna Therapeutics's FCF Yield %

For the Biotechnology subindustry, Kyverna Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyverna Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kyverna Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kyverna Therapeutics's FCF Yield % falls into.


Kyverna Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kyverna Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-53.031 / 0
=N/A%

Kyverna Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-26.068 * 4 / 1070.981568
=-9.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyverna Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kyverna Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kyverna Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyverna Therapeutics (Kyverna Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
N/A
Address
5980 Horton Street, STE 550, Emeryville, CA, USA, 94608
Website
https://www.kyvernatx.com
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR.

Kyverna Therapeutics (Kyverna Therapeutics) Headlines

From GuruFocus

Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering

By PRNewswire • 02-12-2024